Tissue microstructural changes are independently associated with cognitive impairment in cerebral amyloid angiopathy

Anand Viswanathan1, Pratik Patel, Rosanna Rahman

  • 1Hemorrhagic Stroke Research Program, Massachusetts General Hospital, Stroke Research Center, 175 Cambridge Street, Suite 300, Boston, MA 02114, USA. aviswanathan1@partners.org

Stroke
|April 26, 2008
PubMed
Abstract

Insights

Higher mean apparent diffusion coefficient (mean ADC) on MRI is linked to cognitive impairment in cerebral amyloid angiopathy (CAA). This finding suggests mean ADC may detect distinct microstructural damage in CAA patients.

Area of Science:

  • Neurology
  • Radiology
  • Neuroimaging

Background:

  • Cerebral amyloid angiopathy (CAA) is a significant cause of stroke and cognitive decline.
  • CAA is associated with white matter changes and microbleeds.
  • Diffusion tensor imaging (DTI) can reveal microstructural damage in CAA.

Purpose of the Study:

  • To investigate the association between global mean apparent diffusion coefficient (mean ADC) and cognitive impairment in patients with CAA.
  • To determine if elevated mean ADC, indicating chronic tissue disruption, is independently linked to CAA-related cognitive impairment.

Main Methods:

  • Cognitive function was assessed using the IQCODE questionnaire in 49 patients.
  • MRI-derived measures including white matter hyperintensities, microbleeds, and mean ADC were collected.
  • Measures were taken from the hemisphere unaffected by intracerebral hemorrhage to minimize confounding factors.

Main Results:

  • Cognitive impairment was present in 10 of 49 patients.
  • Mean ADC was significantly higher in patients with cognitive impairment (12.4x10(-4) mm(2)/s) compared to those without (11.7x10(-4) mm(2)/s).
  • Mean ADC was independently associated with cognitive impairment after controlling for age and atrophy (OR=2.45).

Conclusions:

  • Mean ADC is an independent predictor of cognitive impairment in CAA.
  • Mean ADC may reflect distinct pathological aspects of CAA not captured by other MRI markers.
  • Global MRI diffusion changes are sensitive to microstructural alterations and useful for assessing CAA-related tissue damage.

Related Concept Videos

Alzheimer Disease ll: Pathophysiology01:23

Alzheimer Disease ll: Pathophysiology

Alzheimer disease involves structural changes in the brain that begin long before symptoms appear. The most distinctive features are extracellular neuritic plaques and intracellular neurofibrillary tangles.Neuritic plaques form in the cerebral cortex and around blood vessels. These plaques contain a dense core of beta-amyloid (Aβ)—a toxic protein fragment that clumps outside neurons. The core is surrounded by damaged neuronal extensions, as well as reactive astrocytes and microglia. Abnormal...
Dementia l: Introduction01:22

Dementia l: Introduction

Dementia is an acquired, progressive syndrome characterized by a decline in multiple cognitive domains severe enough to impair daily functioning and reduce independence. Although memory loss is a central feature, the diagnosis requires additional deficits involving language, executive function, visuospatial skills, judgment, calculation, or abstract reasoning. These cognitive impairments reflect underlying neurodegenerative or vascular processes that gradually disrupt neuronal networks...
Alzheimer Disease l: Introduction01:29

Alzheimer Disease l: Introduction

Alzheimer disease is a chronic, progressive, and irreversible neurodegenerative disorder and the most common cause of dementia in older adults. It leads to gradual neuronal loss, causing cognitive decline, behavioral changes, and loss of functional independence.Risk Factors and EtiologyThe disease is multifactorial. Age is the strongest risk factor, with prevalence doubling every 5 years after age 65. Genetic factors include mutations in genes such as APP, PSEN1, and PSEN2, which are associated...
Alzheimer's Disease: Overview01:26

Alzheimer's Disease: Overview

Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ and tau...